Recurrent Melanoma No Longer Available Phase Trials for Pembrolizumab (DB09037)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)No Longer AvailableNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03311542Expanded Access for Pembrolizumab (MK-3475)